Flomics is developing a multi-purpose liquid biopsy, dynamic and capable of detecting multiple complex diseases even before the first symptoms appear. Our technology combines optimized plasma cell-free RNA (cfRNA) profiling with state-of-the-art machine learning data analysis implemented in the cloud to detect warning signs in an accurate, fast and minimally invasive way, everything out of a simple blood sample.